Related content

A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

By Plard Christine   Bressolle Françoise   Fakhoury May   Zhang Daolun   Yacouben Karina   Rieutord André   Jacqz-Aigrain Evelyne  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 621-621

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and Pharmacokinetic Risk Factors for High-dose Methotrexate-induced Toxicity in Children with Acute Lymphoblastic Leukemia: A Logistic Regression Analysis

By Rask Charlotte   Albertioni Freidoun   Bentzen Soeren M.   Schroeder Henrik   Peterson Curt  

Acta Oncologica, Vol. 37, Iss. 3, 1998-07 ,pp. : 277-284

Informa Healthcare

Access to resources Recommend Favorite

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

By Thompson Patrick   Murry Daryl   Rosner Gary   Lunagomez Simon   Blaney Susan   Berg Stacey   Camitta Bruce   Dreyer ZoAnn   Bomgaars Lisa  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 847-853

Springer Publishing Company

Access to resources Recommend Favorite

Evaluating Intestinal Permeability by Measuring Plasma Endotoxin and Diamine Oxidase in Children with Acute Lymphoblastic Leukemia Treated with High-dose Methotrexate

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 3, 2016-02 ,pp. : 387-392

Bentham Science Publishers

Access to resources Recommend Favorite

Ik6 expression provides a new strategy for the therapy of acute lymphoblastic leukemia

By            

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1373-1379

Spandidos Publications

Access to resources Recommend Favorite